Biotech Values

[nerdseeksblonde]

the globeimmune patents
potentially relate to the company globeimmune which
could be a biotech company doing something related to these patents.

Apparently there is only one that is assigned to them:
$ usptopat2 -wide -browse -app -search "an/globeimmune"
an/globeimmune
20060110755 Yeast-based therapeutic for chronic hepatitis C infection

But 3 that mention them:

$ usptopat2 -wide -browse -search globeimmune
[ nothing found ]
$ usptopat2 -wide -browse -app -search globeimmune
20060110755 Yeast-based therapeutic for chronic hepatitis C infection
20050031640 Vaccination and immunotherapy as new therapeutic modalities in t
he treatment of glaucoma
20040156858 Yeast-based vaccines as immunotherapy

20060110755 no:2
Inventors: Duke; Richard C.; (Denver, CO) ; Franzusoff; Alex; (Denver, CO) ; Haller; Aurelia; (Boulder, CO) ; King; Thomas H.; (Denver, CO)
Yeast-based therapeutic for chronic hepatitis C infection
Disclosed are compositions, including vaccines, and methods for vaccinating an animal against hepatitis C virus (HCV) and for treating or preventing hepatitis C viral infection in an animal. The invention includes a variety of novel HCV fusion proteins that can be used directly as a vaccine or in conjunction with a yeast-based vaccine vehicle to elicit an immune response against HCV in an animal. The invention also includes the use of the HCV fusion gene and protein described herein in any diagnostic or therapeutic protocol for the detection and/or treatment or prevention of HCV infection.
20050031640 no:3 May 25, 2006
Inventors: Chynn, Emil William; (New York, NY)
Vaccination and immunotherapy as new therapeutic modalities in the treatment of glaucoma
This invention provides a method whereby a vaccine, particularly a vaccine based on a prophylactic or therapeutic AIDS/HIV vaccine, or other immune-reactive substance is administered to produce an immunologic response that decreases intraocular pressure or has a neuro-protective effect beneficial in the treatment of glaucoma patients. The invention may also be used as a provocative test to diagnose glaucoma as well as identify those patients at risk for developing glaucoma. The invention may also be used to prevent the development of glaucoma in patients deemed to be at high risk of developing glaucoma, such as glaucoma suspects or ocular hypertensive patients.
20040156858 no:4 February 10, 2005
Inventors: Franzusoff, Alex; (Denver, CO) ; Bellgrau, Donald; (Denver, CO)
Yeast-based vaccines as immunotherapy
Compositions and methods for treating and/or preventing a variety of diseases and conditions that are amenable to immunotherapy and, in one particular embodiment, compositions and methods for treating and/or preventing cancer in an animal are described. Specifically improvements related to the use of a yeast-based vaccine comprising a yeast vehicle and an antigen that is selected to elicit an antigen-specific cellular and humoral immune response in an animal, for use in prophylactic and/or therapeutic vaccination and the prevention and/or treatment of a variety of diseases and conditions are disclosed.